Prosecution Insights
Last updated: May 29, 2026

Examiner: CHEN, CATHERYNE

Tech Center 1600 • Art Units: 1655

This examiner grants 37% of resolved cases

Performance Statistics

37.4%
Allow Rate
-22.6% vs TC avg
825
Total Applications
+18.4%
Interview Lift
1554
Avg Prosecution Days
Based on 776 resolved cases, 2023–2026

Rejection Statute Breakdown

3.2%
§101 Eligibility
12.4%
§102 Novelty
71.3%
§103 Obviousness
3.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18088198 MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION Final Rejection THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
18171670 IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT Final Rejection Andong National University Industry-Academic Cooperation Foundation
18042889 NEW SYSTEM WITH EMERGING PROPERTIES FOR USE IN THE TREATMENT OF METABOLIC SYNDROME Non-Final OA Aboca S.p.A. Società Agricola
18840761 THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS Non-Final OA Native Code Bio, LLC
18615328 STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES Non-Final OA FIGENE, LLC
18392701 COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS Non-Final OA JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18444191 HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF Non-Final OA KBS Research, LLC
18395764 METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF Non-Final OA TCI CO., LTD.
18556692 COMPOSITION COMPRISING A PHYTOCOMPLEX FROM POMEGRANATE AND ITS USES Non-Final OA ESSERRE PHARMA SRL
18028097 COMPOSITION COMPRISING FLAVANOL MONOMERS AND E-VINIFERIN Non-Final OA ACTIV'INSIDE
18514609 NUTRACEUTICAL COMPOSITION AND METHOD FOR THE PROTECTION OF HUMAN ARTERIAL ENDOTHELIAL CELLS FROM ENDOTHELIAL CELL DYSFUNCTION Non-Final OA K.L.R.M., LLC
18511413 CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS Non-Final OA Nutrition21, LLC
17833297 SYSTEMS AND METHODS FOR MANUFACTURING API-CONTAINING EDIBLES, AND RESULTING EDIBLE PRODUCTS Final Rejection Transport Authority, Inc.
18287342 PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITION COMPRISING A MIXTURE OF PLANTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES Non-Final OA BIONEXX EUROPE
18558841 STABLE BIOACTIVE COMPOSITION Non-Final OA LINTBELLS LIMITED
18033964 MATRIX METALLOPROTEASE 1 EXPRESSION INHIBITOR, SKIN EXTERNAL AGENT, AND USE FOR INHIBITION OF MATRIX METALLOPROTEASE 1 EXPRESSION Non-Final OA DSR CORPORATION
18498563 FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION Non-Final OA TURTLE BEAR HOLDINGS, LLC
18493383 CHELIDONIUM MAJUS EXTRACTS AND COMPOSITIONS Non-Final OA PHYTHERA THERAPEUTICS INC
18047098 EXTRACTION PROCESS Non-Final OA SPECNOVA LLC
18195895 METHOD TO HARVEST INSECTS, EGGS, AND LARVAE Final Rejection Lavaca River Ranch, LTD.
17290629 BIO-PESTICIDE OIL FORMULATION Non-Final OA Indian Oil Corporation Limited
17164231 COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME Non-Final OA Unigen, Inc.
17418003 Therapeutic Drug for Disease Accompanied by Disorders in Retinal Cells or Retinal Tissue Non-Final OA RACTHERA Co., Ltd.
16930564 COMPOSITIONS FOR TREATING OBESITY Final Rejection Truetiva, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month